Barna, M.E. et al. 2013. Oral Agents for Treatment of Patients with Advanced Pancreatic Neuroendocrine Tumors: Could Pharmaeconomic, Cost-Effectiveness Data Play a Significant Role?. JOP. Journal of the Pancreas. 14, 1 (Jan. 2013), 102–104. DOI:https://doi.org/10.6092/1590-8577/1354.